sites 的問題，透過圖書和論文來找解法和答案更準確安心。 我們找到下列包括價格和評價等資訊懶人包

Hiking Ruins Seldom Seen Southern New England: A Guide to 40 Sites in Massachusetts, Connecticut and Rhode Island

為了解決sites 的問題，作者Kipfer, Barbara Ann,Dr Bellantoni, Nicholas F. 這樣論述：

Dr. Barbara Ann Kipfer is the author of 14,000 things to be happy about (with more than 1.25 million copies in print). She has written more than 80 books and calendars, mostly lists, including 5,203 Things to Do Instead of Looking at Your Phone, Self-Meditation, Instant Karma, 8,789 Words of Wisdom,

and The Wish List (Workman), 4,000 Questions for Getting to Know Anyone and Everyone (Random House), Roget’s International Thesaurus (HarperCollins), and 1,001 Ways to Live Wild, 1,001 Ways to Slow Down, and 1,001 Ways to be Creative (National Geographic), and the forthcoming Hiking is Fundamental

(Falcon Guides). Dr. Kipfer holds a PhD in Archaeology (Greenwich University), a PhD and MPhil in Linguistics (University of Exeter), an MA (Greenwich University) and PhD in Buddhist Studies (Akamai University), and a BS in Physical Education from Valparaiso University. She is the Senior Lexicograph

er of Zeta Global and has worked for companies such as Google, Dictionary.com, General Electric Research, IBM Research, idealab, and WolframAlpha. She is a Registered Professional Archaeologist. Her website is www.thingstobehappyabout.com. Barbara is now an avid hiker and learning new things with ea

ch hike. Dr. Nicholas F. Bellantoni is emeritus Connecticut State Archaeologist and an associate research professor in the Department of Anthropology in the University of Connecticut. He served as the state archaeologist with the Connecticut State Museum of Natural History and Archaeology Center in

the College of Liberal Arts & Sciences at the University of Connecticut. He earned his BA in Anthropology at the Central Connecticut State University and his MA in Anthropology at University of Connecticut. He received his doctorate in Anthropology from UConn in 1987 and was shortly thereafter appoi

nted state archaeologist. He retired from that position in 2014. Dr. Bellantoni is the co-editor of In Remembrance: Archaeology and Death (1997) and has also contributed to journals such as the Journal of Forensic Science, Journal of Archaeological Science, and to the American Journal of Physical An

thropology. He most recently has authored The Long Journeys Home: The Repatriations of Henry ’Opukaha’ia and Albert Afraid of Hawk and And So The Tomb Remained: Exploring Archaeology and forensic Science in Connecticut’s Historical Family Mausolea. He has been excavating in Connecticut for over 40 y

ears.

sites 進入發燒排行的影片

History of the Great Central Railway

為了解決sites 的問題，作者Jones, Robin 這樣論述：

The Great Central Railway is the only double track preserved steam railway in the world and its main focus is on the hugely popular modern day line running between Loughborough and Leicester North. Author Robin Jones, editor of Heritage Railway magazine, uses an incredible collection of images fr

om Britain’s top railway photographers to showcase the very best of preserved steam running in an authentic setting. History has its place too with the formation of the original Great Central Railway, built in 1899 to connect the cities of Manchester, Sheffield and London, being explained and examin

ed. Preservation sites set up elsewhere on the former Great Central line are also detailed including those at Buckinghamshire Railway Centre, Elsecar Heritage Railway and Dinting Railway Centre in Glossop

An Integrated Approach For Uncovering Novel DNA Methylation Biomarkers For Non-small Cell Lung Carcinoma

為了解決sites 的問題，作者VAIBHAV KUMAR SUNKARIA 這樣論述：

Introduction - Lung cancer is one of primal and ubiquitous cause of cancer related fatalities in the world. Leading cause of these fatalities is non-small cell lung cancer (NSCLC) with a proportion of 85%. The major subtypes of NSCLC are Lung Adenocarcinoma (LUAD) and Lung Small Cell Carcinoma (LUS

C). Early-stage surgical detection and removal of tumor offers a favorable prognosis and better survival rates. However, a major portion of 75% subjects have stage III/IV at the time of diagnosis and despite advanced major developments in oncology survival rates remain poor. Carcinogens produce wide

spread DNA methylation changes within cells. These changes are characterized by globally hyper or hypo methylated regions around CpG islands, many of these changes occur early in tumorigenesis and are highly prevalent across a tumor type.Structure - This research work took advantage of publicly avai

lable methylation profiling resources and relevant comorbidities for lung cancer patients extracted from meta-analysis of scientific review and journal available at PubMed and CNKI search which were combined systematically to explore effective DNA methylation markers for NSCLC. We also tried to iden

tify common CpG loci between Caucasian, Black and Asian racial groups for identifying ubiquitous candidate genes thoroughly. Statistical analysis and GO ontology were also conducted to explore associated novel biomarkers. These novel findings could facilitate design of accurate diagnostic panel for

practical clinical relevance.Methodology - DNA methylation profiles were extracted from TCGA for 418 LUAD and 370 LUSC tissue samples from patients compared with 32 and 42 non-malignant ones respectively. Standard pipeline was conducted to discover significant differentially methylated sites as prim

ary biomarkers. Secondary biomarkers were extracted by incorporating genes associated with comorbidities from meta-analysis of research articles. Concordant candidates were utilized for NSCLC relevant biomarker candidates. Gene ontology annotations were used to calculate gene-pair distance matrix fo

r all candidate biomarkers. Clustering algorithms were utilized to categorize candidate genes into different functional groups using the gene distance matrix. There were 35 CpG loci identified by comparing TCGA training cohort with GEO testing cohort from these functional groups, and 4 gene-based pa

nel was devised after finding highly discriminatory diagnostic panel through combinatorial validation of each functional cluster.Results – To evaluate the gene panel for NSCLC, the methylation levels of SCT(Secritin), FOXD3(Forkhead Box D3), TRIM58(Tripartite Motif Containing 58) and TAC1(Tachikinin

1) were tested. Individually each gene showed significant methylation difference between LUAD and LUSC training cohort. Combined 4-gene panel AUC, sensitivity/specificity were evaluated with 0.9596, 90.43%/100% in LUAD; 0.949, 86.95%/98.21% in LUSC TCGA training cohort; 0.94, 85.92%/97.37 in GEO 66

836; 0.91,89.17%/100% in GEO 83842 smokers; 0.948, 91.67%/100% in GEO83842 non-smokers independent testing cohort. Our study validates SCT, FOXD3, TRIM58 and TAC1 based gene panel has great potential in early recognition of NSCLC undetermined lung nodules. The findings can yield universally accurate

and robust markers facilitating early diagnosis and rapid severity examination.